Platform
Features
Pricing
Kurome Therapeutics
Contact
Daniel Heller as General Partner and Chief Investment Officer at Affinity Asset Advisors, former Director of Research at Perceptive Advisors and founding Board Member at Silagene Inc.
This person is not in the org chart
11 members
Civatech Oncology
Trishula Therapeutics
Hansa Medical
IHPBA: International Hepato Pancreato Biliary Association
Ascelia Pharma